USPTO serial 97248240
SAL6830
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BAKER, JORDAN A
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SAL6830?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Southampton, Hampshire, GB
Southampton, Hampshire, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Todd A. Denys
Todd A. Denys PORZIO, BROMBERG & NEWMAN, P.C.600 ALEXANDER ROAD, SUITE 2-1PRINCETON, NJ 08540UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Enzyme preparations for medical purposes; enzymes for medical purposes; chemical reagents for medical or veterinary purposes; reagents for medical diagnostic testing of bodily fluids | ACTIVE | — |
| 010 | Medical diagnostic instruments for the analysis of body fluids; Medical devices for diagnostic analysis of biological molecules; Medical apparatus for use in analysis of body fluids; Diagnostic apparatus for medical purposes for the analysis of body fluids; Medical diagnostic apparatus for medical purposes namely, diagnosis of infectious diseases, Medical diagnostic apparatus for testing for viruses or for infectious disease; Testing instruments for medical diagnostic purposes, namely, testing for the presence of infectious diseases and analytes; Instruments for use in the field of clinical diagnosis, namely, diagnosis of infectious diseases; Diagnostic imaging apparatus for medical use, namely, automated fluorescence based detection; Apparatus for nucleic acid testing for medical purposes; Sample collection apparatus for medical use, namely, collection of biological fluids and bodily fluids for analysis; Kits for testing for the presence of analytes in biological fluids, other fluids and other matrices, all for medical purposes, comprised of a sample collection tube, biological fluid testing apparatus, PCR plates, and printed ID barcode; Biomedical devices in the nature of cartridges for loading biological samples for use in molecular diagnostic devices; Testing sample collection equipment, namely, apparatus for obtaining biological samples from subjects in the nature of collection cups, collection apparatus, and collection vessels; Medical diagnostic testing apparatus for diagnosis of COVID-19, namely for testing of biological samples using polymerase chain reaction | ACTIVE | — |
| 044 | Medical diagnostic services, namely, medical diagnostic testing, monitoring, and reporting services; Medical testing for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes, particularly, for the treatment of persons; Medical information; Medical services; Medical screening; Medical analysis services relating to the diagnosis and treatment of persons; Medical information services; Medical information services, namely, compilation of medical reports; Medical clinic services; Medical equipment rental; Medical health assessment services; Medical information retrieval services; Medical examination of individuals; Mobile medical clinic services; Medical testing services relating to the diagnosis and treatment of disease; Performing rapid, on-site diagnosis of diseases; Medical analysis services for the diagnosis of disease; Nucleic acid analysis for disease diagnosis and screening services; Medical diagnosis services, namely, virus screening services; Medical diagnosis services, namely, on-site virus screening and testing services; Medical testing services, namely, testing bodily fluid for the presence of analytes; Medical services for the analysis of samples from patients for diagnosis and treatment purposes; Medical services for diagnosis of COVID-19 | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MicroGEM International Plc
- Other trademarks owned by MicroGEM International Plc
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named SAL6830
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 25, 2023 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 25, 2023 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 21, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 27, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 27, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 7, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 18, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 18, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 18, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 18, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 18, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 16, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Oct 25, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Oct 12, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 28, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 27, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 27, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 8, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 8, 2022 | ATRQ | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED | — |
| Aug 8, 2022 | ATRQ | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED | — |
| Aug 8, 2022 | ATRQ | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED | — |
| Aug 8, 2022 | PCGR | PETITION TO DIRECTOR GRANTED | — |
| Aug 1, 2022 | APET | ASSIGNED TO PETITION STAFF | — |
| Jun 30, 2022 | TPDR | TEAS PETITION TO DIRECTOR RECEIVED | — |
| Feb 7, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 4, 2022 | NWAP | NEW APPLICATION ENTERED | — |